Follow
Deepa Jonnalagadda
Deepa Jonnalagadda
Postdoctoral Associate
Verified email at sbpdiscovery.org
Title
Cited by
Cited by
Year
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
7422019
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
4472021
Platelet secretion is kinetically heterogeneous in an agonist-responsive manner
D Jonnalagadda, LT Izu, SW Whiteheart
Blood, The Journal of the American Society of Hematology 120 (26), 5209-5216, 2012
2402012
Fingolimod: lessons learned and new opportunities for treating multiple sclerosis and other disorders
J Chun, Y Kihara, D Jonnalagadda, VA Blaho
Annual review of pharmacology and toxicology 59, 149-170, 2019
902019
Granule-mediated release of sphingosine-1-phosphate by activated platelets
D Jonnalagadda, M Sunkara, AJ Morris, SW Whiteheart
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2014
552014
A functionally defined in vivo astrocyte population identified by c-Fos activation in a mouse model of multiple sclerosis modulated by S1P signaling: immediate-early astrocytes …
A Groves, Y Kihara, D Jonnalagadda, R Rivera, G Kennedy, M Mayford, ...
ENeuro 5 (5), 2018
442018
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, AA Mathie, ...
British journal of pharmacology 180, S23-S144, 2023
372023
Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P1‐selective modulation
Y Kihara, D Jonnalagadda, Y Zhu, M Ray, T Ngo, C Palmer, R Rivera, ...
The FASEB Journal 36 (2), 2022
152022
Single-nucleus RNA-seq of normal-appearing brain regions in relapsing-remitting vs. secondary progressive multiple sclerosis: implications for the efficacy of fingolimod
Y Kihara, Y Zhu, D Jonnalagadda, W Romanow, C Palmer, B Siddoway, ...
Frontiers in Cellular Neuroscience 16, 918041, 2022
142022
A soluble epoxide hydrolase inhibitor, 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-Yl) urea, ameliorates experimental autoimmune encephalomyelitis
D Jonnalagadda, D Wan, J Chun, BD Hammock, Y Kihara
International journal of molecular sciences 22 (9), 4650, 2021
142021
CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries
C Abi-Ghanem, D Jonnalagadda, J Chun, Y Kihara, B Ranscht
Frontiers in Cellular Neuroscience 16, 908401, 2022
62022
S1P2-Gα12 signaling controls astrocytic glutamate uptake and mitochondrial oxygen consumption
D Jonnalagadda, Y Kihara, R Rivera, J Chun
Eneuro 8 (4), 2021
62021
FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis
D Jonnalagadda, Y Kihara, A Groves, M Ray, A Saha, C Ellington, ...
Cell Reports 42 (12), 2023
42023
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
HA Stephen P, A Christopoulos, PD Anthony, E Kelly, A Mathie, AP John, ...
BRITISH JOURNAL OF PHARMACOLOGY 178, 2021
22021
Lysophospholipid (S1P) receptors in GtoPdb v. 2021.2
V Blaho, J Chun, D Jones, D Jonnalagadda, Y Kihara, VP Tan
IUPHAR/BPS Guide to Pharmacology CITE 2021 (2), 2021
12021
Lysophospholipid (S1P) receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database
V Blaho, J Chun, D Jones, D Jonnalagadda, Y Kihara, V Tan
IUPHAR/BPS Guide to Pharmacology CITE 2020 (5), 2020
12020
Differential CNS effects of siponimod vs. fingolimod revealed by single-cell nuclear transcriptome analyses of human primary astrocytes
Y Kihara, Y Zhu, D Jonnalagadda, C Liu, B Siddoway, J Chun
MULTIPLE SCLEROSIS JOURNAL 25, 533-533, 2019
12019
Heterogeneity in platelet secretion
D Jonnalagadda, SW Whiteheart
The FASEB Journal 23, 877.2-877.2, 2009
12009
CNS MECHANISMS OF S1P RECEPTOR SIGNALING IN MULTIPLE SECLEROSIS
J Chun, Y Kihara, V Tan, A Shahnaee, D Jonnalagadda, C Palmer, C Liu
IBRO Neuroscience Reports 15, S12, 2023
2023
Lysophospholipid (S1P) receptors in GtoPdb v. 2023.1
V Blaho, J Chun, D Herr, D Jones, D Jonnalagadda, Y Kihara
IUPHAR/BPS Guide to Pharmacology CITE 2023 (1), 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20